Online Exclusives

Online Exclusives

CMS Expands Access to CAR T-Cell Therapies Nationwide

The Centers for Medicare and Medicaid Services (CMS) will now provide “consistent and predictable” nationwide access to chimeric antigen receptor (CAR) T-cell therapies, according...

Doctors Rally to Support Disabled Indian Medical School Applicants in Legal Case

Doctors and medical groups from the U.S., U.K., and Australia expressed their opposition to a recent decision from the Medical Council of India (MCI)...

Immune Globulin Shortages Force Hospitals to Ration Treatments

A shortage of immune globulin (IG) is forcing hospitals to ration the drug and prioritize its use for patients who need it the most....

Hospitals and Drug Makers Provide Little Information on Patient DNA Collection

As gene sequencing becomes more common, hospitals and pharmaceutical companies have struck deals to collect and mine genetic information for drug development, but these...

Federal Authorities Question Ethics of “Pay-to-Play” Clinical Trials

The U.S. Food and Drug Administration (FDA) permits clinical trial sponsors to charge patients to participate in research in “extraordinary circumstances,” but, according to...

Will Canada Allow U.S. to Import Drugs?

The Trump administration said it will create a system to allow for the legal importation of lower-cost prescription drugs from Canada, a first following...

Purdue Pharma and Founding Family Facing Legal Action for Opioid Epidemic

Oxycontin manufacturer Purdue Pharma is attempting to distance itself from its role in the opioid epidemic by urging a Massachusetts judge to dismiss a...

Trump Administration May Force Hospitals to Disclose Discount Rates with Insurers

Under a newly proposed Trump administration rule, hospitals would have to disclose the discounted prices they negotiate with insurance companies. The objective of the...

California Fines Pharmaceutical Companies $70 Million for Colluding to Keep Generics Off the Market

Several pharmaceutical companies will have to pay nearly $70 million to the state of California for colluding to keep generic drugs off the market...

Medicare Increases Coverage of CAR T-Cell Therapy

The Centers for Medicare and Medicaid Services (CMS) has issued a final rule that raises payments for new technologies, including chimeric antigen receptor (CAR)...
Advertisement

Current Issue

August 2019, Volume 5, Issue 10

August 2019, Volume 5, Issue 10

This issue features a debate about gun control as a health care issue, a look at blood services in Israel and Palestine, and more.